SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Improving blood donor screening by nucleic acid technology (NAT)
11 references·2 citing·37 second hop
Improving blood donor screening by nucleic acid technology (NAT) (2010)Improving blood donor screening by nuclei…Alternative strategies in assuring blood safety: An Overview (2010)Alternative strategies in ass…Transfusion medicine and safety (2009)Transfusion medicine and safe…Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus (2008)Experience of German Red Cros…A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)A new strategy for estimating…High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan (2003)High throughput screening of …Yield of HCV and HIV‐1 NAT after screening of 3.6 million blood donations in central Europe (2002)Yield of HCV and HIV‐1 NAT af…The German experience with NAT (2002)The German experience with NATNAT and Viral Safety In Blood Transfusion (2000)NAT and Viral Safety In Blood…Genomic screening for blood-borne viruses in transfusion settings (2000)Genomic screening for blood-b…Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting (1999)Feasibility and efficacy of r…Confidential unit exclusion: the North London Blood Transfusion Centre's experience (1995)Confidential unit exclusion: …Assessing risks of infection with herpes viruses during transfusion of donor blood and its components (2020)Assessing risks of infection …Impact of grey zone sample testing by enzyme-linked immunosorbent assay in enhancing blood safety: Experience at a tertiary care hospital in North India (2015)Impact of grey zone sample te…Current incidence and estimated residual risk of transfusion‐transmitted infections in donations made to Canadian Blood Services (2007)Human immunodeficiency virus test‐seeking blood donors in a large blood bank in São Paulo, Brazil (2010)The Politics of Blood (2012)Screening tests for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus in blood donors: Evaluation of two chemiluminescent immunoassay systems (2014)Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests (1995)The Risk of Transfusion-Transmitted Viral Infections (1996)Prevention of transfusion‐transmitted hepatitis E by donor‐initiated self exclusion (2005)Surveillance of risk profiles among new and repeat blood donors with transfusion‐transmissible infections from 1995 through 2003 in the Netherlands (2006)Prevalence of HIV among blood donors in a tertiary care centre of north India (2011)Prevalence of selected viral infections among temporarily deferred donors who returned to donate blood: American Red Cross blood donor study (2005)Risques viraux émergents en transfusion sanguine (2011)The Management of Blood Safety in the Presence of Uncertain Risk: A United Kingdom Perspective (2011)The contribution of unsafe blood transfusion to human immunodeficiency virus incidence in sub‐Saharan Africa: reexamination of the 5% to 10% convention (2016)The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection (1997)Window‐period human immunodeficiency virus transmission to two recipients by an adolescent blood donor (2004)One‐year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations (2009)Nucleic acid testing (NAT) in high prevalence–low resource settings (2010)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)Transfusion-transmitted infections (2007)Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing (2010)Prevention of transfusion-transmitted infections (2019)Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States (1995)Nucleic acid amplification testing of blood donors fortransfusion‐transmitted infectious diseases (2000)Reducing the risk of infection from plasma products: specific preventative strategies (2000)International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009 (2011)Hepatitis B virus blood screening: unfinished agendas (2006)Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors. (2008)Informative Dorfman Screening (2011)Blood donor screening with cobas s 201/cobas TaqScreen MPX under routine conditions at German Red Cross institutes (2009)Evaluation of two, commercial, multi‐dye, nucleic acid amplification technology tests, for HBV/HCV/HIV‐1/HIV‐2 and B19V/HAV, for screening blood and plasma for further manufacture (2012)Three-Year Experience in NAT Screening of Blood Donors for Transfusion Transmitted Viruses in Croatia (2017)Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions (2009)Nucleic acid testing for blood banks: An experience from a tertiary care centre in New Delhi, India (2013)History and Future of Nucleic Acid Amplification Technology Blood Donor Testing (2019)[Risk of transfusional-transmitted infections]. (2002)Sufficient blood, safe blood: can we have both? (2012)
this work references cited by second hop

References

  • 2005A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors426 cited
  • 1999Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting254 cited
  • 2008Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus189 cited
  • 2003High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan101 cited
  • 2002Yield of HCV and HIV‐1 NAT after screening of 3.6 million blood donations in central Europe91 cited
  • 2000Genomic screening for blood-borne viruses in transfusion settings58 cited
  • 2009Transfusion medicine and safety47 cited
  • 2000NAT and Viral Safety In Blood Transfusion44 cited
  • 2002The German experience with NAT40 cited
  • 2010Alternative strategies in assuring blood safety: An Overview34 cited
  • 1995Confidential unit exclusion: the North London Blood Transfusion Centre's experience14 cited

Cited by

  • 2015Impact of grey zone sample testing by enzyme-linked immunosorbent assay in enhancing blood safety: Experience at a tertiary care hospital in North India8 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2020Assessing risks of infection with herpes viruses during transfusion of donor blood and its components8 cited